Published November 9, 2026
The email arrives just before nine on Monday, the morning the new drip menu was meant to go live. Google has disapproved most of the new ads, the reason reads "Healthcare and medicines", and the nurses are already booked for a busy week.
A disapproved ad costs you a few days of bookings. A suspended account costs you every booking search was bringing in, in every city at once, and an account restricted for health content is one of the reasons owners give for looking for a new marketing partner.
Neither Google's healthcare policy nor Meta's health and wellness standard names IV therapy. What they restrict is what an ad and its landing page claim, which drug names appear, and what health data you send back to them. Keep your ads to the treatment, the nurse and the visit, let your medical director approve any claim about what a drip does, and let your attorney confirm anything legal.
Google keeps disapproving IV therapy ads because of what the ad, its keywords or its landing page say, not because they sell IV therapy, which Google's healthcare and medicines policy never mentions by name. The policy restricts categories, and a drip menu can touch several of them without anyone meaning to.
Start with drug names. Google restricts the use of prescription drug terms in ads, landing pages and keywords. A menu page that lists a prescription medication as an add-on can trip the policy even when the ad itself only says "mobile IV". The same page also bars the promotion of speculative or experimental medical treatments, so a drip described as cutting edge or as new science invites the wrong review.
Your menu page is often where the trouble starts, because it is written once and then sits behind every ad you run. If it names add-ons, go through each name with your medical director and decide whether it needs to sit on a page your ads point to at all.
Then come claims. Google's misrepresentation policy bars claims that entice people with an improbable result, and clickbait that uses illness to push someone into acting now. A headline promising that a drip will fix how you feel by tonight fits both.
Open each disapproval in Google Ads, write down the exact policy it names, and fix the landing page as well as the ad, because Google reads both.
Yes, IV therapy businesses run Google Ads without suspensions, and it helps to know the difference between a disapproved ad and a suspended account before you panic. A disapproval stops one ad, while a suspension stops the whole account and every city it serves.
Google treats some misrepresentation as egregious and says accounts are suspended "upon detection and without prior warning." The example on its list closest to your business is "pretending to provide medical help." For an IV company, that means every page should say plainly who gives the infusion, who oversees the treatment and which areas you serve. Overstating any of those is a bigger risk than a weak headline. If the people giving infusions hold different licenses in different cities, name each license city by city instead of calling everyone a nurse, and let your medical director confirm the wording.
Nobody can promise that your account will never be reviewed. What you control is how fast a disapproval gets fixed and whether the same claim keeps returning in new ads, written by a new person who never saw the first warning.
Ask whoever runs your account to show you every disapproval from the last 90 days, with the policy named and what changed afterward.
An IV business can describe the treatment, the ingredients its menu lists, the licensed nurse who gives it and the visit itself. Claims about what an infusion does for the body belong in your ads only when your medical director has approved them and the evidence behind them exists.
The FTC has drawn this line before. Its first action against an IV therapy business, announced on 20 September 2018, targeted iV Bars, whose "iV Cocktails" were promoted as treating conditions such as cancer, congestive heart failure and multiple sclerosis. The FTC alleged those claims were unsupported, and the proposed order barred them without competent and reliable scientific evidence, the standard the FTC's chairman said every health claim must meet.
Researchers have also examined claims on IV websites like yours. A JAMA Internal Medicine study of 255 IV hydration websites found most made broad claims about immunity or wellness, and only two cited a source, as the American Med Spa Association reported on 10 October 2025.
The split below is a practice we suggest for deciding who signs off each kind of line, not a rule from Google or the FTC.
| What the line says | Example | Suggested sign-off |
|---|---|---|
| The service | A licensed nurse comes to your home or hotel | Your marketing lead, checked against how visits really run |
| What is in the bag | Ingredients exactly as your menu lists them | Your medical director, who can approve the menu wording once and review it when the menu changes |
| What it does for the body | More energy, faster recovery, stronger immunity | Your medical director, with the evidence, before it runs |
| A disease or condition | Anything the drip treats, cures or prevents | Keep it out of ads, and ask your attorney if anyone insists |
Sending every health claim to your medical director before it runs is built into the digital marketing for IV therapy businesses we run, and you can run the same check without us. Write the claims your ads and pages use into one list, have your medical director sign it, and treat anything missing from the list as unapproved.
LegitScript certification is something Google's healthcare policy asks for in the US from online pharmacies, telemedicine providers and addiction services, and IV therapy is not on that list. You'll still hear in owner forums that every IV business needs it before Google will run its ads.
The telemedicine rule may apply to the consultation in your booking process. Google's US telemedicine rule covers websites that provide virtual healthcare services and facilitate prescribing. If your booking flow includes a video visit with a prescriber who then orders the drip, your site may look like telemedicine to Google, whatever you call it.
The question matters most when you open a new state and the prescriber who orders your drips works remotely.
Map your booking flow from first click to the nurse's arrival. If a remote consult with a prescriber sits anywhere in it, ask Google's support team which category your site falls into before you spend, and have your attorney read the answer.
Meta's ad standards don't name IV therapy either, and the line that matters most for a drip ad is the one against text that says or implies the person reading has a health condition. Its personal attributes standard allows "New diabetes treatment available" and rejects "Do you have diabetes?" A headline that opens with the reader's symptom can read the same way, so lead with the service and the visit.
Weight loss is its own case. Meta's health and wellness standard requires ads for weight loss products and health supplements to target people 18 or older, and sends prescription weight loss products to its drugs policy. If your menu sells either, check the audience on every ad set.
Meta also limits the health data advertisers send back from their websites, which changes how its campaigns optimize. Read what Meta's health data limits mean for IV ads before you judge a Meta campaign by its own conversion count.
State law adds a layer of its own. In Texas, HB 3749 set who a physician may delegate ordering and giving elective IV therapy to from 1 September 2025, and your Texas ads should describe the process you run under it.
Before the next launch, read each Meta headline aloud and ask whether it describes your service or the reader.
For IV therapy businesses we plan search and social ads, SEO and AI search, booking pages, email and SMS together, and every ad, page and email clears the same health checks before it runs.
The Mobile IV Growth Audit reviews your ads against health ad rules and follows the path from lead to completed treatment in each city. Our first reply comes within 1 business day, and you get the audit no more than 10 business days after access arrives.
Get Your Mobile IV Growth AuditA disapproval stops the ad it names. Google keeps suspension without warning for violations it treats as egregious, and its examples include posing as a provider of medical care. Treat each disapproval as a reason to fix the page behind the ad, so the problem doesn't spread to new campaigns.
A review becomes your ad once you run it. If a patient writes that a drip cured her migraines, that line makes a medical claim on your behalf. It goes to your medical director like any claim you wrote yourself, and it usually stays out.
For claims, yes. The FTC's 2018 IV case covered what the company said on its website and social media, and Google checks the landing page each ad points to. Check your emails for the same promises you keep out of your ads.
Approve every health claim, which is different from approving every ad. A signed list lets your marketing team write new ads fast, and only a claim that isn't on the list goes back for review.
Mike Le
Co-Founder, CB/I Digital and Conative AI
Mike Le co-founded CB/I Digital in New York in 2007 and has helped brands grow through search, paid media and data ever since. He started the agency's AI team in 2019 and later started Conative AI. He writes about how customers find and choose brands now that AI answers sit between them and the search results.
Follow Mike on LinkedInCopyright © 2026 CB/I DIGITAL INC. All rights reserved | Privacy Policy